A novel BODIPY-based theranostic agent for in vivo fluorescence imaging of cerebral Aβ and ameliorating Aβ-associated disorders in Alzheimer's disease transgenic mice

Authors:

Abstract
We report the synthesis, characteristics, and biological evaluations of a novel theranostic agent, P14, for both in vitro and in vivo imaging of central Aβ plaques, inhibition of Aβ aggregation, and neuronal damage as well as behavioral deficits.
Funding Information
  • China Postdoctoral Science Foundation (No. 2019M661669)
  • National Natural Science Foundation of China (No. 82003724)
  • Science and Technology Commission of Shanghai Municipality (2018SHZDZXO5)

This publication has 29 references indexed in Scilit: